Changes in BASF's Executive Board of Directors

Coatings World group

首页> 外文期刊>Coatings World >Changes in BASF's Executive Board of Directors

【24h】

Changes in BASF's Executive Board of Directors

机译：巴斯夫执行董事会的变动

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The Supervisory Board of BASF SE has appointed Sanjeev Gandhi to the Board of Executive Directors effec- tive December 1, 2014. He has been head of BASF's Intermediates division since 2010.

机译：自2014年12月1日起，巴斯夫股份公司监事会任命Sanjeev Gandhi为执行董事会成员。他自2010年以来一直担任巴斯夫中间体业务部主管。

著录项

来源
《Coatings World》 |2014年第11期|共1页
作者
Coatings World group;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类涂料工业;
关键词

相似文献

外文文献
中文文献
专利

1. Changes in the Board of Executive Directors of BASF [J] . Coatings World group Coatings World . 2017,第1期

机译：巴斯夫执行董事会的变化
2. Changes in the Board of Executive Directors of BASF [J] . Chemical Business Group Chemical Business . 2012,第1期

机译：巴斯夫执行董事会的变动
3. Changes in the Board of Executive Directors of BASF [J] . Polyurethanes Magazine International Group Polyurethanes Magazine International: PU Magazine . 2012,第1期

机译：巴斯夫执行董事会的变动
4. IT, Senior Executives and Board of Directors Contribute to the Success of the Business: Implicates on the IT Demand Process--Life Cycle [C] . Alonso Igor Aguilar, Verdún José Carrillo, Caro Edmundo Tovar International Conference on Computer Sciences and Convergence Information Technology;ICCIT '09 . 2009

机译：IT，高级管理人员和董事会为业务成功做出了贡献：牵连到IT需求流程-生命周期
5. Decision-Making at the Executive Level: How Boards of Trustees and Search Firms Hire Art Museum Executive Directors [D] . ?Riley, Devin 2020

机译：执行级别的决策：受托人和搜索公司如何聘请艺术博物馆执行董事
6. Interaction between non-executive and executive directors in English National Health Service trust boards: an observational study [O] . Rod Sheaff, Ruth Endacott, Ray Jones, 2015

机译：英格兰国家卫生局信托委员会中非执行董事与执行董事之间的互动：一项观察性研究
7. ACC/AHA/ASNC Guidelines for the Clinical Use of Cardiac Radionuclide Imaging—Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging)44The ACC/AHA Task Force on Practice Guidelines makes every effort to avoid any actual or potential conflicts of interest that might arise as a result of an outside relationship or personal interest of a member of the writing panel. Specifically, all members of the writing panel are asked to provide disclosure statements of all such relationships that might be perceived as real or potential conflicts of interest. These statements are reviewed by the parent task force, reported orally to all members of the writing panel at the first meeting, and updated as changes occur.55This document was approved by the American College of Cardiology Foundation Board of Trustees in July, 2003, the American Heart Association Science Advisory and Coordinating Committee in July, 2003, and the American Society of Nuclear Cardiology Board of Directors in July, 2003.66When citing this document, the American College of Cardiology Foundation, the American Heart Association, and the American Society of Nuclear Cardiology request that the following citation format be used: Klocke FJ, Baird MG, Bateman TM, Berman DS, Carabello BA, Cerqueira MD, DeMaria AN, Kennedy JW, Lorell BH, Messer JV, O’Gara PT, Russell RO Jr, St. John Sutton MG, Udelson JE, Verani MS, Williams KA. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging—executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Radionuclide Imaging). J Am Coll Cardiol 2003;42:1318–33.77(J Am Coll Cardiol 2003;42:1318–33)88©2003 by the American College of Cardiology Foundation and the American Heart Association, Inc. [O] . Klocke Francis J, Baird Michael G, Lorell Beverly H, 2003

机译：ACC / AHA / ASNC心脏放射性核素成像临床使用指南-执行摘要美国心脏病学会/美国心脏协会实践指南工作组的报告（ACC / AHA / ASNC委员会，对1995年临床使用指南进行修订ACC / AHA实践指导小组）竭尽全力避免由于写作小组成员的外部关系或个人利益而引起的任何实际或潜在的利益冲突。具体来说，要求写作小组的所有成员提供所有可能被视为实际或潜在利益冲突的关系的披露声明。这些声明由上级工作组审查，在第一次会议上向书面小组的所有成员口头报告，并在发生变化时进行更新。55本文件于2003年7月获得美国心脏病学会基金会董事会的批准。 2003年7月，美国心脏协会科学咨询与协调委员会，2003年7月，美国核心脏病学会理事会。66引用该文件时，美国心脏病学会基金会，美国心脏协会和美国核学会心脏病学要求使用以下引用格式：Klocke FJ，Baird MG，Bateman TM，Berman DS，Carabello BA，Cerqueira MD，DeMaria AN，Kennedy JW，Lorell BH，Messer JV，O'Gara PT，Russell RO Jr，St John Sutton MG，Udelson JE，Verani MS，Williams KA。 ACC / AHA / ASNC心脏放射性核素成像临床使用指南-执行摘要：美国心脏病学会/美国心脏协会实践小组工作指南（ACC / AHA / ASNC委员会，修订1995年临床指南）的报告使用放射性核素成像）。 J Am Coll Cardiol 2003; 42：1318–33.77（J Am Coll Cardiol 2003; 42：1318–33）88©2003美国心脏病学会基金会和美国心脏协会版权所有。

Changes in BASF's Executive Board of Directors

摘要

著录项

相似文献

相关主题

期刊订阅